Frontal lobal dysfunction in patients with non-frontal malignant gliomas: A monoaminergic dysregulation?

Medical Hypotheses

Volumn 53, Issue 3, 1999, Pages 190-193

  Lilja, Å ^a   Skagerberg, G ^a   Salford, L G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; BIOGENIC AMINE;

ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; DOPAMINERGIC TRANSMISSION; FRONTAL LOBE; GLIOBLASTOMA; HUMAN; METABOLISM; NEUROPSYCHOLOGY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; TUMOR LOCALIZATION; ANIMAL; BIOLOGICAL MODEL; BLOOD FLOW; BRAIN TUMOR; GLIOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL MODEL; REVIEW; SYNAPTIC TRANSMISSION; VASCULARIZATION;

ANIMALS; BIOGENIC MONOAMINES; BRAIN NEOPLASMS; FRONTAL LOBE; GLIOMA; HUMANS; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; REGIONAL BLOOD FLOW; SYNAPTIC TRANSMISSION;

EID: 0032589993     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0744     Document Type: Article

References (27)

1. Lilja Å., Salford L. G., Smith G. J. W. Neuropsychological indexes of a partial ' frontal syndrome' in patients with non-frontal gliomas. Neuropsychology. 4:1992;315-326.
2. Lilja Å., Hagstadius S., Risberg J., Salford L. G., Smith G. J. W., Öhman R. Frontal lobe dynamics in brain tumor patients: a study of regional cerebral blood flow and affective changes before and after surgery. Neuropsychiatr Neurpsychol Behav Neurol. 5:1992;294-300.
3. Lange K. W., Robbins T. W., Marsden C. D., James M., Owen A. M., Paul G. M. L-dopa withdrawal in patients with Parkinsons disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology. 107:1992;394-404.
4. Lilja Å., Smith G. J. W., Salford L. G. Microprocesses in perception and personality. J Nerv Ment Dis. 2:1992;82-88.
5. Lilja Å., Sjöholm H., Rosen I., Salford L. G. High grade nonfrontal gliomas are associated with frontal hypoperfusion on SPECT and behavioral disturbances of frontal networks. J Neuro-oncol. submitted.
6. Lilja, Å. Salford, L. G. Early mental changes in patients with astrocytomas with special reference to anxiety and epilepsia, Psychopathology.
7. Beninger R. J. The role of dopamine in locomotor activity and learning. Brain Res Rev. 6:1983;173-196.
8. Cloninger C. R. Brain networks underlying personality development. Caroll B. J., Barett J. E. Psychopathology and the Brain. 1991;183-204 Raven Press, New York.
9. Goldman-Rakic P. S. Dopamine-mediated mechanisms of the prefrontal cortex. Sem Neurosci. 4:1992;149-150.
10. Toshiyuki S., Goldman-Rakic P. S. dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1991;947-950.
11. Müller U., Cramon Y. The therapeutic potential of bromocriptine in neuropschological rehabilitation of patients with acquired brain damage. Progr Neuro-Psychopharmacol Biol Psychiat. 18:1994;1103-1120.
12. Kobari M., Fukuuchi Y., Shinohara T., Obara K., Nagawa S. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders. J Neurol Sci. 128:1995;212-218.
13. Grasby P. M., Friston K. J., Bench C. J. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychol Med. 23:1993;605-612.
14. Daniel D. G., Weinberger D. R., Jones D. W. The effect of amphetamine on regional cerebral blood flow during dognitive activation in schizophrenia. J Neurosci. 11:1991;1907-1917.
15. Jaskiw G. E., Weinberger D. R. Dopamine and schizophrenia - cortically corrective perspective. Sem Neurosci. 4:1992;179-188.
16. Williams G. V., Goldman-Rakic P. S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
17. Sontheimer H. Glial influences on neuronal signaling. The Neuroscientist. 1:1995;123-126.
18. During J. M., Ryder M. K., Spencer D. D. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376:1995;174-177.
19. Kitayama S., Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J Pharmacol. 72:1996;195-208.
20. Xu W., Emson P. C. Neuronal stem cells express vesicular monoamine transporter 2 immunoreactivity in the adult rat. Neuroscience. 76:1997;7-10.
21. Abell, C. W. Synthesis, function, and degradation of catecholamine neurotransmitters, van Ree, J. M.Mathysse, S. Progress in Brain Research vol. 65, Elsevier Science Publishers, Amsterdam, 1986, 139, 152.
22. Student A. K., Edwards D. J. Subcellular localization of type A and B monoamine oxidase in rat brain. Biochem Pharmacol. 209:1977;339-354.
23. Jaber M., Robinson S. W., Missale C., Caron M. G. Dopamine receptors and brain function. Neuropharmacol. 35:1996;1503-1519.
24. Smith K. A., Fairburn C. G., Cowen P. J. Relapse of depression after rapid depletion of tryptophan. Lancet. 349:1997;915-919.
25. Wurtman R. J., Larin F., Mostafapour S., Fernstrom J. D. Brain catecholamine synthesis: control by brain tyrosine concentration. Science. 185:1974;183-184.
26. Anisman H., Zacharko R. M. Stress and neoplasia. Speculations and caveats. Behav Med Update. 5:1983;27-35.
27. Blanc G., Herv D., Simon H., Lisoprawski A., Glowinski J., Tassin J. P. Response to stress of mesocortico-frontal dopaminergic neurones in rats ofter long-term isolation. Nature. 284:1980;265-267.